  |
|
|||||||||||||||||||||
   |
||||||||||||||||||||||
| About | Ahead of print | Current Issue | Archive | Search | Instructions | Announcement | Etcetera | Contact | Advertise |
|
||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||||
|
 Reader
Comments
Year : 2009 | Volume: 41 | Issue Number: 1 CORRESPONDENCESurrogate end points and their role in clinical trials: Reply from authors Kalikar M V, Thawani V R, Varadpande U K, Sontakke S D, Singh R P, Khiyani R K
|
|||||||||||||||
|
|
| Online since 20th July '04 | |
| Published by Medknow |
